CHANGES IN PLATELET ACTIVITY AND BLOOD COAGULATION PARAMETERS IN PATIENTS AFTER CORONARY STENTING.
Abstract
Coronary artery disease (CAD) remains one of the leading causes of cardiovascular mortality worldwide. Percutaneous coronary intervention (PCI), including coronary stenting, is a minimally invasive procedure that effectively restores blood flow in patients with coronary artery disease. However, stent implantation causes endothelial damage and increased platelet activation, which increases the risk of stent thrombosis and restenosis. Therefore, monitoring hemostasis and platelet status after the procedure is of great clinical importance.
References
1. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to N. Engle J. 2001;345:494–502.
CAPRIE Steering Committee. A randomized, single-blind trial of clopidogrel. Lancet. 1996;348:1329–1339.
2.Bhatt DL, Fox CAA, Haque W, et al. Clopidogrel and aspi. N. 2006;354:1706–1717.
3.Windecker S, Kohl P, Alfonso F, et al. The 2014 ESC/EACTS guidelines. Eur Heart J. 2014;35:2541–2619.
4.Angiolillo JD, Fernandez-Ortiz A, Bernardo E, et al. Platel J. 2007;49:2074–2088.
5.Sibbing D, Aradi D, Jacobshagen K, et al. Guidelines for dual antiplatelet therapy. Thrombus He. 2010;104:817–828.
6.Armstrong PW, Welsh RK, Gersh BJ, et al. Percutaneous Coronary Intervention and Circulation. 2006;114:2623–2630.
7.Dangas G, Mehran R, Kereiakes J, et al. Stent Thrombus Circulation. 2010;121:1335
8.Mehran R, Baber W, Steg PG, et al. Duration of dual antiplatelet therapy. J Am Coll Cardiol. 2013;62:1213–1223.
9.Sibbing D, Schultz S, Brown S, et al. Platelet function monitoring in patients. Clin 2011;57:1093–1104.
